Search Results

Filter
  • 1-10 of  126,188 results for ""BIOPHARMACEUTICS""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack.

  • Authors : Kollipara S; Biopharmaceutics Group, Global Clinical Management, Dr. Reddy's Laboratories Ltd., Integrated Product Development Organization (IPDO), Bachupally, Medchal Malkajgiri District, Hyderabad, 500090, Telangana, India. .; Prabhat PK

Subjects: Mesalamine*/Mesalamine*/Mesalamine*/pharmacokinetics ; Mesalamine*/Mesalamine*/Mesalamine*/administration & dosage ; Mesalamine*/Mesalamine*/Mesalamine*/chemistry

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Dec 02; Vol. 26 (1), pp. 1. Date of Electronic Publication: 2024 Dec 02.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

×
Academic Journal

Justification of widened dissolution specifications of an extended-release product using physiologically based biopharmaceutics modeling.

  • Authors : Bhattiprolu AK; Biopharmaceutics Group, Global Clinical Management, Dr. Reddy's Laboratories Ltd., Integrated Product Development Organization (IPDO), Hyderabad, Telangana, India.; Kollipara S

Subjects: Biopharmaceutics*/Biopharmaceutics*/Biopharmaceutics*/methods ; Delayed-Action Preparations* ; Therapeutic Equivalency*

  • Source: Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2024 Oct; Vol. 54 (10), pp. 781-795. Date of Electronic Publication: 2024 Oct 14.Publisher: Informa Healthcare Country of Publication: England NLM ID: 1306665 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Semi-Mechanistic Physiologically Based Biopharmaceutics Model to Describe Complex and Saturable Absorption of Metformin: Justification of Dissolution Specifications for Extended Release Formulation.

  • Authors : Bhattiprolu AK; Biopharmaceutics Group, Global Clinical Management, Dr. Reddy's Laboratories Ltd., Integrated Product Development Organization (IPDO), BachupallyMedchal Malkajgiri District, Hyderabad, Telangana, 500 090, India.; Kollipara S

Subjects: Metformin*/Metformin*/Metformin*/pharmacokinetics ; Metformin*/Metformin*/Metformin*/administration & dosage ; Metformin*/Metformin*/Metformin*/chemistry

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Aug 21; Vol. 25 (7), pp. 193. Date of Electronic Publication: 2024 Aug 21.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

×
Editorial & Opinion

Development of in vitro biopharmaceutics tools for predicting the bioavailability of subcutaneously injected monoclonal antibodies and oligonucleotides.

  • Authors : Somby K; King's College London, Institute of Pharmaceutical Science, London, England.; Novartis Pharma AG, Basel, Switzerland.

Subjects: Biological Availability* ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/administration & dosage ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacokinetics

  • Source: Expert opinion on drug delivery [Expert Opin Drug Deliv] 2024 Sep; Vol. 21 (9), pp. 1307-1310. Date of Electronic Publication: 2024 Sep 21.Publisher: Informa Healthcare Country of Publication: England NLM ID: 101228421 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Lack of Effect of Antioxidants on Biopharmaceutics Classification System (BCS) Class III Drug Permeability.

  • Authors : Chiang Yu Y; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, 21201, USA.; Lu D

Subjects: Antioxidants*/Antioxidants*/Antioxidants*/pharmacology ; Antioxidants*/Antioxidants*/Antioxidants*/pharmacokinetics ; Permeability*

  • Source: Journal of pharmaceutical sciences [J Pharm Sci] 2024 Aug; Vol. 113 (8), pp. 2215-2222. Date of Electronic Publication: 2024 Mar 12.Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report.

  • Authors : Pepin X; Regulatory Affairs, Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534-7059, United States.; Arora S

Subjects: Biopharmaceutics*/Biopharmaceutics*/Biopharmaceutics*/methods ; Models, Biological*; Humans

  • Source: Molecular pharmaceutics [Mol Pharm] 2024 Aug 05; Vol. 21 (8), pp. 3697-3731. Date of Electronic Publication: 2024 Jun 30.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report.

  • Authors : Mackie C; Janssen Pharmaceutica NV, Turnhoutseweg 30, Beerse 2340, Belgium.; Arora S

Subjects: Biopharmaceutics*/Biopharmaceutics*/Biopharmaceutics*/methods ; Drug Industry*/Drug Industry*/Drug Industry*/methods; Humans

  • Source: Molecular pharmaceutics [Mol Pharm] 2024 May 06; Vol. 21 (5), pp. 2065-2080. Date of Electronic Publication: 2024 Apr 10.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Drug solubility in biorelevant media in the context of an inhalation-based biopharmaceutics classification system (iBCS).

  • Authors : Floroiu A; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany; Eurofins PHAST Development GmbH & Co. KG, 78467 Konstanz, Germany. Electronic address: .

Subjects: Biopharmaceutics* ; Intestines*; Pharmaceutical Preparations/Pharmaceutical Preparations/Pharmaceutical Preparations/chemistry

  • Source: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Neural Network Models for Predicting Solubility and Metabolism Class of Drugs in the Biopharmaceutics Drug Disposition Classification System (BDDCS).

  • Authors : Ashrafi A; Faculty of Electrical and Computer Engineering, University of Tabriz, Tabriz, Iran.; Teimouri K

Subjects: Biopharmaceutics*/Biopharmaceutics*/Biopharmaceutics*/methods ; Neural Networks, Computer*; Solubility

  • Source: European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Jan; Vol. 49 (1), pp. 1-6. Date of Electronic Publication: 2023 Oct 21.Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

iBCS: 3. A Biopharmaceutics Classification System for Orally Inhaled Drug Products.

  • Authors : Hastedt JE; JDP Pharma Consulting, San Carlos, California 94070, United States.; Bäckman P

Subjects: Biopharmaceutics*/Biopharmaceutics*/Biopharmaceutics*/methods ; Nebulizers and Vaporizers*; Solubility

  • Source: Molecular pharmaceutics [Mol Pharm] 2024 Jan 01; Vol. 21 (1), pp. 164-172. Date of Electronic Publication: 2023 Dec 07.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-10 of  126,188 results for ""BIOPHARMACEUTICS""